Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 3/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | IL1RN | P18510 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30901134 | 1.00 | F2 (0.57) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL31439621 | 0.98 | F2 (0.56) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL2405304 | 0.83 | F2 (0.61) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL29964265 | 0.83 | F2 (0.61) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL30901132 | 0.82 | CA2 (0.46) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL30901133 | 0.82 | CA2 (0.46) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL6517138 | 0.82 | CA2 (0.46) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL4093243 | 0.82 | ALDH1A1 (0.55) | CA1CA2ALDH1A1LMNACA12 | |
| SCHEMBL31196958 | 0.82 | GAA (0.55) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL9674696 | 0.82 | F2 (0.59) | F2PRSS1PRSS2PRSS3CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2866029-A1 | METHOD FOR PREPARING SAMPLE CONTAINING PANCREATIC JUICE COMPONENT, AND KIT FOR STORING BIOLOGICAL SAMPLE CONTAINING PANCREATIC JUICE COMPONENT AT ROOM TEMPERATURE | Olympus Corporation (JP) | 2015-04-29 | — | — | EP | claimed |
| CN-104395749-A | Method for preparing sample containing pancreatic juice component, and kit for storing biological sample containing pancreatic juice component at room temperature | OLYMPUS CORP | 2015-03-04 | — | — | CN | claimed |
| EP-2757151-A1 | METHOD FOR INHIBITING PROTEASE IN BIOLOGICAL SAMPLE CONTAINING PANCREATIC JUICE COMPONENT | Olympus Corporation (JP) | 2014-07-23 | — | — | EP | claimed |
| US-20140186869-A1 | METHOD FOR INHIBITING PROTEASE IN BIOLOGICAL SAMPLE CONTAINING PANCREATIC JUICE COMPONENTS | OLYMPUS CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260042806-A1 | NOVEL PORE MONOMERS AND PORES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-02-12 | — | — | US | disclosed |
| EP-4665733-A1 | AMINO-SUBSTITUTED PYRROLOTRIAZINE DERIVATIVES AS INHIBITORS OF SGK1 | Bristol-Myers Squibb Company (US) | 2025-12-24 | — | — | EP | disclosed |
| US-12390424-B2 | Sulfur (VI) fluoride compounds and methods for the preparation thereof | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-08-19 | — | — | US | disclosed |
| WO-2025136134-A1 | DIMETHYLBIPHENYL COVALENT PD-L1/PD-1 INTERACTION INHIBITOR COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAID INHIBITOR AND THE USE THEREOF | Uniwersytet Jagielloński (PL) | 2025-06-26 | — | — | WO | disclosed |
| EP-4569330-A1 | NOVEL PORE MONOMERS AND PORES | Oxford Nanopore Technologies PLC (GB) | 2025-06-18 | — | — | EP | disclosed |
| US-20240309020-A1 | KRAS G12D INHIBITORS | ARRAY BIOPHARMA INC. | 2024-09-19 | — | — | US | disclosed |
| WO-2024173323-A1 | AMINO-SUBSTITUTED PYRROLOTRIAZINE DERIVATIVES AS INHIBITORS OF SGK1 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-08-22 | — | — | WO | disclosed |
| US-20100075848-A1 | Laser Imaging | DATALASE LTD. (GB) | 2010-03-25 | — | — | US | disclosed |
| EP-1704057-A1 | LASER IMAGING | Sherwood Technology LTD. (GB) | 2006-09-27 | — | — | EP | disclosed |
| WO-2005068207-A1 | LASER IMAGING | DATALASE LTD. (GB) | 2005-07-28 | — | — | WO | disclosed |
| US-4978607-A | CONTAINING GELATIN, MODIFIED WITH MONOFUNCTIONAL ACID DERIVATIVE, AND HARDENER, A CARBAMOYL PYRIDINIUM SALT; WITHOUT RETICULATED GRAIN | AGFA-GEVAERT AKTIENGESSELLSCHAFT (DE) | 1990-12-18 | — | — | US | disclosed |
| US-4407939-A | GELATIN MODIFIED WITH SUCCINIC, PHTHALIC OR TRIMELLITIC ANHYDRIDE POSITIONED BETWEEN | FUJI PHOTO FILM CO., LTD. (JP) | 1983-10-04 | — | — | US | disclosed |
| US-4051303-A | RECORDING SHEET | FUJI PHOTO FILM CO., LTD. (JA) | 1977-09-27 | — | — | US | disclosed |
| US-4021245-A | GELATION DERIVATIVE, SILICIC ACID ANHYDRIDE | FUJI PHOTO FILM CO., LTD. (JA) | 1977-05-03 | — | — | US | disclosed |
| US-3944502-A | Process for preparing microcapsules containing hydrophobic oil drops | FUJI PHOTO FILM CO., LTD. (JA) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12390424-B2 | Sulfur (VI) fluoride compounds and methods for the preparation thereof | GRB2, SCTR, OGFR | F2 929/4885PRSS1 2129/4885PRSS2 1293/4885 |
| US-12630566-B2 | KRas G12D inhibitors | KRAS, NRAS, HRAS | F2 3533/4885PRSS1 1338/4885PRSS2 2677/4885 |
| US-20260042806-A1 | NOVEL PORE MONOMERS AND PORES | SCNN1G, CACNG3, ASIC3 | F2 1607/4885PRSS1 1357/4885PRSS2 2116/4885 |
| US-20240309020-A1 | KRAS G12D INHIBITORS | KRAS, NRAS, HRAS | F2 2972/4885PRSS1 1587/4885PRSS2 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.